DPR-2 Inhibitors
Chemical inhibitors of DPR-2 serve as tools to dissect the signaling pathways that regulate its function within cellular contexts. PD 98059 and U0126 can target the MAPK/ERK pathway, which is a significant regulatory pathway for many proteins. These inhibitors can prevent the activation of MEK1/2, leading to a consequential reduction in ERK activity. Inhibition of ERK activity by these chemicals can directly affect DPR-2 if its function is contingent upon ERK-mediated phosphorylation. Similarly, LY294002 operates by inhibiting PI3K, leading to a decrease in Akt phosphorylation and subsequent signaling activities. If DPR-2 activity relies on the PI3K/Akt pathway, then its function can be diminished by LY294002. Additionally, Rapamycin and Torin 1 can inhibit the mTOR pathway, which, if DPR-2's activity is intertwined with, will result in its inhibition by constraining the signaling that promotes growth and proliferation processes.
Further along these lines, SB203580 and SP600125 can modulate DPR-2 activity by targeting p38 MAPK and JNK, respectively. These inhibitors can impede the p38 MAPK and JNK pathways, potentially disrupting the phosphorylation and activation of downstream targets that may include DPR-2. PP2, targeting the Src family kinases, can lead to the inhibition of various signaling cascades, which may affect DPR-2 if it is a downstream effector of these kinases. Y-27632, by inhibiting ROCK, can affect cytoskeletal dynamics, which could be crucial for the function of DPR-2 if it plays a role in those processes. PF-562271 and WZ4003, which inhibit FAK and NUAK family kinases, respectively, can also lead to a reduction in DPR-2 activity if it is implicated in cell adhesion, migration, or other cellular functions governed by these kinases. Lastly, Dorsomorphin can inhibit BMP signaling and, by extension, can modulate DPR-2 activity if DPR-2 is regulated by or participates in the BMP pathway.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which is upstream of the MAPK/ERK pathway. By inhibiting MEK, PD 98059 prevents the activation of ERK, which could inhibit the phosphorylation of DPR-2, assuming that DPR-2 is regulated by ERK-mediated phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. It inhibits PI3K activity leading to a decrease in Akt phosphorylation. If DPR-2 activity is dependent on PI3K/Akt pathway signaling, then LY294002 will inhibit DPR-2 function by suppressing this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it prevents downstream signaling that may be necessary for DPR-2 function, such as regulation of cytoskeletal dynamics, which could be crucial for DPR-2's role in the cell. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. Inhibition of JNK activity could lead to reduced activity of transcription factors that regulate the expression and function of DPR-2, thus inhibiting DPR-2's function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2. MEK inhibition can lead to reduced ERK activity, which might be necessary for DPR-2 function if DPR-2 is downstream of the ERK signaling pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases can regulate multiple cellular processes that might be essential for DPR-2 function, so inhibition by PP2 could result in decreased DPR-2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of ROCK, Rho-associated protein kinase. If DPR-2 is involved in pathways regulated by ROCK, such as cytoskeletal arrangement, then Y-27632 would inhibit DPR-2 by inhibiting ROCK. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $312.00 $474.00 $1124.00 | 3 | |
PF-562271 is a focal adhesion kinase (FAK) inhibitor. If DPR-2 is involved in cell adhesion or migration that requires FAK signaling, then PF-562271 would inhibit DPR-2 by inhibiting FAK. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the PI3K/AKT/mTOR pathway. If DPR-2 is involved in cellular processes regulated by mTOR, such as growth and proliferation, then Rapamycin would inhibit DPR-2 by inhibiting mTOR. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
WZ4003 is a NUAK family kinase inhibitor. If DPR-2 is a substrate or is regulated by NUAK kinases, inhibiting these kinases with WZ4003 would result in DPR-2 inhibition. | ||||||